Heart Failure Post-Hematopoietic Cell Transplantation in Patients With Lymphoma: Another Piece of the CHIP Puzzle

Overview

Journal JACC CardioOncol

Date 2025 Feb 3

PMID 39896119

Authors

Oscar Calvillo-Arguelles

Robert J Vanner

Affiliations

Soon will be listed here.

References

Gibson C, Kim H, Zhao L, Murdock H, Hambley B, Ogata A . Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation. J Clin Oncol. 2021; 40(2):189-201. PMC: 8718176. DOI: 10.1200/JCO.21.02286. View

Yura Y, Cochran J, Walsh K . Therapy-Related Clonal Hematopoiesis: A New Link Between Cancer and Cardiovascular Disease. Heart Fail Clin. 2022; 18(3):349-359. PMC: 9219036. DOI: 10.1016/j.hfc.2022.02.010. View

Mammadova J, Colin-Leitzinger C, Nguyen D, Mhaskar R, Ganesan S, Tang Y . Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO Precis Oncol. 2023; 7:e2300208. PMC: 10581654. DOI: 10.1200/PO.23.00208. View

Gibson C, Lindsley R, Tchekmedyian V, Mar B, Shi J, Jaiswal S . Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. J Clin Oncol. 2017; 35(14):1598-1605. PMC: 5455707. DOI: 10.1200/JCO.2016.71.6712. View

Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman P, Mar B . Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014; 371(26):2488-98. PMC: 4306669. DOI: 10.1056/NEJMoa1408617. View

Lyon A, Lopez-Fernandez T, Couch L, Asteggiano R, Aznar M, Bergler-Klein J . 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022; 43(41):4229-4361. DOI: 10.1093/eurheartj/ehac244. View

Weeks L, Ebert B . Causes and consequences of clonal hematopoiesis. Blood. 2023; 142(26):2235-2246. PMC: 10862247. DOI: 10.1182/blood.2023022222. View

Bolton K, Gillis N, Coombs C, Takahashi K, Zehir A, Bejar R . Managing Clonal Hematopoiesis in Patients With Solid Tumors. J Clin Oncol. 2018; 37(1):7-11. PMC: 6354773. DOI: 10.1200/JCO.18.00331. View

Schuermans A, Honigberg M, Raffield L, Yu B, Roberts M, Kooperberg C . Clonal Hematopoiesis and Incident Heart Failure With Preserved Ejection Fraction. JAMA Netw Open. 2024; 7(1):e2353244. PMC: 10811556. DOI: 10.1001/jamanetworkopen.2023.53244. View

10.

Coombs C, Zehir A, Devlin S, Kishtagari A, Syed A, Jonsson P . Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. Cell Stem Cell. 2017; 21(3):374-382.e4. PMC: 5591073. DOI: 10.1016/j.stem.2017.07.010. View

11.

Krishan S, Munir M, Khan M, Al-Juhaishi T, Nipp R, DeSimone C . Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation. Europace. 2023; 25(5). PMC: 10198774. DOI: 10.1093/europace/euad129. View

12.

Calvillo-Arguelles O, Schoffel A, Capo-Chichi J, Abdel-Qadir H, Schuh A, Carrillo-Estrada M . Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations. JACC CardioOncol. 2022; 4(1):38-49. PMC: 9040128. DOI: 10.1016/j.jaccao.2021.11.008. View

13.

Goldsmith S, Shouse G, Wong F, Bosworth A, Iukuridze A, Chen S . Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy. Transplant Cell Ther. 2024; 30(9):927.e1-927.e9. DOI: 10.1016/j.jtct.2024.06.008. View

14.

Dorsheimer L, Assmus B, Rasper T, Ortmann C, Ecke A, Abou-El-Ardat K . Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure. JAMA Cardiol. 2018; 4(1):25-33. PMC: 6439691. DOI: 10.1001/jamacardio.2018.3965. View

15.

Calvillo-Arguelles O, Jaiswal S, Shlush L, Moslehi J, Schimmer A, Barac A . Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review. JAMA Cardiol. 2019; 4(4):380-387. DOI: 10.1001/jamacardio.2019.0302. View

16.

Lin A, Bapat A, Xiao L, Niroula A, Ye J, Wong W . Clonal Hematopoiesis of Indeterminate Potential With Loss of Enhances Risk for Atrial Fibrillation Through Inflammasome Activation. Circulation. 2024; 149(18):1419-1434. PMC: 11058018. DOI: 10.1161/CIRCULATIONAHA.123.065597. View